Geron Ownership | Who Owns Geron?
Geron Ownership Summary
Geron is owned by 71.73% institutional investors, 0.08% insiders, and 28.19% retail investors. Ra capital management is the largest institutional shareholder, holding 9.56% of GERN shares. State Street® SPDR® S&P® Biotech ETF is the top mutual fund, with 3.34% of its assets in Geron shares.
GERN Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Geron | 71.73% | 0.08% | 28.19% |
| Sector | Healthcare Stocks | 244.59% | 12.11% | -156.70% |
| Industry | Biotech Stocks | 379.61% | 11.70% | -291.31% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Ra capital management | 63.77M | 9.56% | $95.02M |
| Blackrock | 46.55M | 7.71% | $197.38M |
| Blackrock funding, inc. /de | 47.32M | 7.09% | $70.51M |
| Soleus capital management | 41.51M | 6.22% | $61.85M |
| Vanguard group | 35.66M | 5.35% | $47.07M |
| State street | 30.50M | 4.57% | $45.44M |
| Citadel advisors | 21.58M | 3.23% | $32.15M |
| Point72 asset management | 20.46M | 3.07% | $30.48M |
| Clearbridge investments | 19.62M | 2.94% | $29.23M |
| Eversept partners, lp | 18.83M | 2.82% | $28.06M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Lion point capital, lp | 578.00K | 5.15% | $861.22K |
| Stempoint capital lp | 6.65M | 3.01% | $9.38M |
| Soleus capital management | 41.51M | 2.50% | $61.85M |
| Eversept partners, lp | 18.83M | 1.48% | $28.06M |
| Boxer capital | 6.00M | 1.34% | $25.44M |
| Vivo capital | 8.67M | 1.08% | $12.92M |
| Ra capital management | 63.77M | 1.01% | $95.02M |
| Pale fire capital se | 4.89M | 0.64% | $7.28M |
| Kynam capital management, lp | 6.84M | 0.63% | $10.19M |
| Nantahala capital management | 11.22M | 0.62% | $16.73M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Point72 asset management | 20.46M | 0.04% | 20.46M |
| Soleus capital management | 41.51M | 2.50% | 18.22M |
| Citadel advisors | 21.58M | 0.01% | 11.65M |
| Stempoint capital lp | 6.65M | 3.01% | 5.69M |
| Clearbridge investments | 19.62M | 0.03% | 5.38M |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Rtw investments, lp | - | - | -44.11M |
| Deep track capital, lp | - | - | -31.72M |
| Holocene advisors, lp | - | - | -22.20M |
| Adage capital partners gp | - | - | -21.80M |
| Vivo capital | 8.67M | 1.08% | -18.55M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Point72 asset management | 20.46M | 0.04% | 20.46M | $30.48M |
| Vanguard fiduciary trust | 3.84M | 0.00% | 3.84M | $5.71M |
| J. goldman & co lp | 610.66K | 0.03% | 610.66K | $909.88K |
| Two sigma advisers, lp | 385.55K | 0.00% | 385.55K | $528.20K |
| Panagora asset management | 360.85K | 0.00% | 360.85K | $537.66K |
Sold Out
| Holder | Change |
|---|---|
| Newedge advisors | -1.00 |
| Root financial partners | -3.00 |
| True wealth design | -4.00 |
| Ifp advisors | -20.00 |
| Wfa of san diego | -40.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2026 | 266 | 1.53% | 481,100,036 | -3.24% | 71 | 1.30% | 132 | 3.94% | 66 | 15.79% |
| Mar 31, 2026 | 255 | -4.14% | 486,830,840 | 1.73% | 72 | 1.42% | 123 | 29.47% | 56 | -41.05% |
| Dec 31, 2025 | 122 | -53.96% | 156,418,320 | -69.15% | 23 | 0.40% | 34 | -67.62% | 40 | -55.56% |
| Sep 30, 2025 | 125 | -52.11% | 130,616,668 | -74.61% | 19 | 0.33% | 40 | -68.25% | 45 | -37.50% |
| Jun 30, 2025 | 257 | -6.20% | 514,289,584 | 0.89% | 77 | 1.32% | 125 | -10.71% | 71 | 1.43% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| State Street® SPDR® S&P® Biotech ETF | 21.48M | 3.34% | 49.32K |
| Vanguard Morn Total Stk Mkt Idx Investor | 20.45M | 3.19% | 394.70K |
| Vanguard Total Stock Mkt Idx Inv | 20.45M | 3.19% | 394.70K |
| Vanguard MStar Total Stk Mkt Idx Invest | 20.45M | 3.18% | - |
| Vanguard US Total Market Shares ETF | 17.83M | 2.80% | 17.67K |
| BioPharma Credit Ord | 14.12M | 2.22% | 14.12M |
| iShares Russell 2000 ETF | 14.16M | 2.20% | -251.62K |
| Vanguard Explorer Inv | 12.98M | 2.02% | 2.81M |
| ClearBridge SMID Cap Growth | 10.17M | 1.58% | - |
| SPDR® S&P Biotech ETF | 10.09M | 1.58% | 22.55K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Feb 18, 2026 | ROBERTSON MICHELLE | EVP, CHIEF FINANCIAL OFFICER | Sell | $19.12K |
| May 09, 2025 | LAWLIS V BRYAN | - | Buy | $15.67K |
| Feb 27, 2025 | Samuels Scott Alan | EVP, Chief Legal Officer | Buy | $24.15K |
| Feb 27, 2025 | SCARLETT JOHN A | Chairman, President and CEO | Buy | $22.06K |
| Feb 27, 2025 | Ziegler James | EVP, Chief Commercial Officer | Buy | $160.00K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q2 | - | - |
| 2026 Q1 | - | 1 |
| 2025 Q4 | - | - |
| 2025 Q3 | - | - |
| 2025 Q2 | 1 | - |
GERN Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools